Baxalta (United States)
Baxalta is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Baxalta (United States), United States, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
54%
Total
Publications
301
Total Open
Publications
162
Total
Citations
6.3K
Open Access
Percentage
54%
Total
Publications
301
Total Open
Publications
162
Total
Citations
6.3K
Breakdown
Publisher Open
32%
Both
17%
Other Platform Open
5%
Closed
46%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 12%
17
Hybrid 57%
85
No Guarantees 31%
46
Other Platform Open
Domain 77%
51
Institution 21%
14
Other Internet 15%
10
Preprint 9%
6
Public 2%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 51 |
Europe PMC | Domain | 26 |
California Digital Library - eScholarship | Other Internet | 6 |
University of California - eScholarship University of California | Institution | 5 |
Cardiff University - ORCA Online Research @Cardiff | Institution | 4 |
DOI | Other Internet | 3 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 2 |
University of Bristol - Bristol Research | Institution | 2 |
Research Square | Preprint | 2 |
whiterose.ac.uk OAI-PMH Repository | Institution | 1 |